V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009082 | 260005953 | 1.8 | 84 | null | 2014-08-10 | 2014-08-11 | Rituximab | Y | N | 260029183 | CHLORAMBUCIL |
| 260009083 | 260005953 | 1.67 | 88 | Disease modification (D) | 2016-05-16 | 2016-06-02 | Bendamustine +/- Prednisolone | N | N | 260029183 | CHOP |
| 260009084 | 260005954 | 1.62 | 91.4 | Palliative (P) | 2018-07-04 | 2018-07-11 | Rituximab | N | N | 260029186 | RITUXIMAB |
| 260009085 | 260005955 | 1.79 | 63 | Palliative (P) | 2014-06-29 | 2014-06-29 | Rituximab | 02 | N | 260029191 | CAPECITABINE + RT |
| 260009086 | 260012142 | 1.53 | 78 | Curative (C) | 2017-07-25 | 2017-07-26 | Rituximab | null | null | 260029192 | NOT MATCHED |
| 260009087 | 260012142 | 1.91 | null | Curative (C) | 2017-10-14 | 2017-10-14 | Trial Unspecified | 2 | null | 260029192 | CAPECITABINE + CISPLATIN |
| 260009088 | 260005956 | 1.84 | 72.4 | null | 2014-09-09 | 2014-09-11 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | null | 260029195 | CHOP |
| 260009089 | 260012143 | 1.7 | 89 | null | 2015-01-08 | 2015-01-12 | Rituximab | Y | N | 260029196 | NOT MATCHED |
| 260009090 | 260005957 | 1.8 | -1 | Curative (C) | 2016-02-28 | 2016-02-29 | VINCRISTINE | 02 | N | 260029197 | RITUXIMAB |
| 260009091 | 260012144 | 1.84 | null | null | 2014-08-08 | 2014-08-12 | Rituximab | 02 | null | 260029198 | FCR |
| 260009092 | 260015601 | 1.58 | 67.1 | Curative (C) | 2016-11-13 | 2016-11-13 | BENDAMUSTINE | null | N | 260029199 | HYDROXYCARBAMIDE |
| 260009093 | 260015601 | null | 57 | Curative (C) | null | 2018-01-30 | Trial Unspecified | N | null | 260029199 | ESHAP R |
| 260009094 | 260005958 | null | 78.1 | null | 2013-06-13 | 2013-06-23 | Rituximab | 2 | null | 260029201 | RITUXIMAB |
| 260009095 | 260012145 | 1.69 | 75 | null | 2014-07-16 | 2014-08-11 | Cisplatin + Etoposide (3 day) | N | N | 260029202 | RITUXIMAB |
| 260009096 | 260012145 | 0 | 98.7 | Curative (C) | 2017-08-02 | 2017-08-04 | Bendamustine +/- Prednisolone | N | N | 260029202 | RITUXIMAB |
| 260009097 | 260005959 | null | 67.4 | Curative (C) | 2015-04-13 | 2015-06-10 | CHLORAMBUCIL + RITUXIMAB | N | N | 260029207 | RITUXIMAB |
| 260009098 | 260012146 | 1.65 | 85.5 | Disease modification (D) | 2017-08-16 | 2017-08-16 | Rituximab | N | N | 260029209 | RITUXIMAB |
| 260009099 | 260005960 | null | 97 | Curative (C) | 2016-10-11 | 2016-10-25 | Rituximab | N | N | 260029210 | RITUXIMAB |
| 260009100 | 260012147 | 1.63 | 53.3 | null | null | 2016-07-12 | Rituximab | null | null | 260029212 | RITUXIMAB |
| 260009101 | 260012147 | 1.85 | null | Palliative (P) | 2016-09-21 | 2016-09-21 | CHLORAMBUCIL + RITUXIMAB | N | N | 260029212 | TIP |
| 260009102 | 260012147 | 1.78 | 125.5 | Curative (C) | 2017-01-30 | 2017-03-08 | ENZARAD Trial | 99 | null | 260029212 | RITUXIMAB |
| 260009103 | 260012147 | 1.85 | null | Palliative (P) | 2013-07-15 | 2013-07-15 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260029212 | CHLORAMBUCIL + RITUXIMAB |
| 260009104 | 260005961 | null | 108 | null | null | 2017-02-03 | Capecitabine | null | null | 260029218 | TRIAL |
| 260009105 | 260012148 | 1.9 | 84.4 | Curative (C) | 2014-01-04 | 2014-02-06 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260029219 | RITUXIMAB |
| 260009106 | 260012148 | 1.73 | 83.8 | Palliative (P) | 2017-03-24 | 2017-04-04 | CISPLATIN + GEMCITABINE | N | N | 260029219 | RITUXIMAB |
| 260009107 | 260012148 | 1.59 | null | Curative (C) | 2015-11-12 | 2015-11-23 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260029219 | CYCLOPHOSPHAMIDE |
| 260009108 | 260005962 | 1.8 | 80.3 | Curative (C) | 2014-12-05 | 2015-01-02 | Cyclophosphamide High Dose | 2 | null | 260029226 | RITUXIMAB |
| 260009109 | 260012149 | 1.64 | 64.3 | Adjuvant (A) | 2015-10-02 | 2015-10-05 | CVP | null | N | 260029230 | GALLIUM TRIAL |
| 260009110 | 260005963 | 1.75 | 106.4 | Palliative (P) | 2014-04-08 | 2014-04-13 | Rituximab | N | N | 260029231 | RITUXIMAB |
| 260009111 | 260005963 | null | 98 | Curative (C) | 2015-02-23 | 2015-02-23 | Rituximab | 02 | N | 260029231 | CHLVPP |
| 260009112 | 260005964 | null | 79.4 | null | 2015-02-25 | 2015-02-25 | Carboplatin + Etoposide IV 3 day | 2 | null | 260029235 | RITUXIMAB |
| 260009113 | 260005964 | null | 84 | Palliative (P) | 2017-07-25 | 2017-08-08 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260029235 | RITUXIMAB |
| 260009114 | 260005964 | null | 62.1 | Adjuvant (A) | 2016-09-19 | 2016-09-19 | Rituximab (SUBCUTANEOUS Maintenance) | Y | N | 260029235 | RITUXIMAB |
| 260009115 | 260005965 | 1.75 | 70.6 | Curative (C) | 2017-12-16 | 2017-12-16 | GEM-P | Y | N | 260029242 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 260009116 | 260005965 | 1.72 | 88 | Adjuvant (A) | 2014-02-25 | 2014-04-15 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 260029242 | BENDAMUSTINE |
| 260009117 | 260005966 | null | 66.8 | Curative (C) | 2017-12-31 | 2017-12-31 | Rituximab | N | N | 260029245 | RITUXIMAB |
| 260009118 | 260005966 | 1.78 | null | Curative (C) | 2017-05-05 | 2017-05-09 | Bendamustine +/- Prednisolone | N | N | 260029245 | RITUXIMAB |
| 260009119 | 260005967 | 1.52 | 59 | Curative (C) | 2017-05-12 | 2017-05-31 | Rituximab | N | N | 260029247 | CHOP |
| 260009120 | 260005967 | null | 74.1 | Disease modification (D) | 2017-06-04 | 2017-06-22 | Rituximab (Maintenance) | N | N | 260029247 | RITUXIMAB |
| 260009121 | 260015606 | 1.58 | 68.899 | Curative (C) | 2018-02-10 | 2018-02-10 | Rituximab | 02 | N | 260029250 | RITUXIMAB |
| 260009122 | 260005968 | 1.79 | 108.2 | Disease modification (D) | 2017-12-18 | 2018-01-01 | LEAM | N | N | 260029256 | PACIFICO TRIAL |
| 260009123 | 260005969 | 1.69 | 81 | null | 2013-08-06 | 2013-08-12 | Docetaxel 75mg/m2 (21 day) | N | N | 260029258 | CARBOPLATIN + ETOPOSIDE |
| 260009124 | 260005969 | 1.84 | null | Curative (C) | 2016-10-23 | 2016-10-30 | Rituximab (Maintenance) | N | N | 260029258 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009127 | 260005971 | 1.88 | 65.2 | Palliative (P) | 2015-11-21 | 2015-12-21 | EP | N | N | 260029263 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009128 | 260005971 | 1.58 | 0 | Curative (C) | 2016-09-25 | 2016-10-02 | Rituximab | 2 | N | 260029263 | RITUXIMAB |
| 260009129 | 260005972 | 1.59 | null | Curative (C) | 2017-02-10 | 2017-02-26 | PACIFICO TRIAL | N | N | 260029266 | FCR |
| 260009130 | 260005972 | 1.84 | null | Curative (C) | 2014-02-27 | 2014-02-27 | Rituximab (Maintenance) | N | N | 260029266 | GEMCITABINE + PACLITAXEL |
| 260009131 | 260015607 | 1.81 | 67.4 | Curative (C) | 2016-11-02 | 2016-11-02 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260029271 | BENDAMUSTINE |
| 260009132 | 260005973 | 0 | 51 | Palliative (P) | 2014-07-15 | 2014-07-16 | Rituximab | 2 | N | 260029272 | RITUXIMAB |
| 260009133 | 260005974 | 1.65 | 105.2 | Curative (C) | 2014-04-25 | 2014-04-26 | REMODLB TRIAL | N | N | 260029273 | CHLORAMBUCIL |